Bogda Koczwara: Pre-Existing and New CVD in Patients With Cancer Are Associated With Higher Mortality
Bogda Koczwara, Director of Australian Research Centre for Cancer Survivorship at UNSW, Professor of Departament of Medical Oncology at Flinders University, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cancer Medicine, adding:
“Approximately 1 in 5 patients diagnosed with cancer have pre-existing cardiovascular disease (CVD).
Once their finish their treatment, approximately 1 in 4 of those without pre-existing CVD develop new CVD.
Both pre-exisitng and new CVD are associated with higher cancer and CVD mortality.
These are the findings of our latest study led by Md. Mijanur Rahman reporting on data from over 60,000 individuals. Compelling argument for integration of CVD risk assessment pre, during, and after treatment.”
Title: Pre-Existing and Post-Cancer Major Cardiovascular Disease and Their Association With Mortality Outcomes Among Cancer Survivors in Australia
Authors: Md Mijanur Rahman, Katy Bell, Grace Joshy, Michael David, Karen Canfell, David Goldsbury, Bogda Koczwara, Emily Banks, Kazuaki Negishi, Geoff P. Delaney, Mei Ling Yap, Xue Qin Yu
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 25, 2026, 19:37William Wallace: More than 1 in 3 People with Parkinson’s Were Low in B6
-
Oct 25, 2026, 19:36Andrés Felipe Escobar González: Individualized Treatment Strategies for HMB in BDUC
-
Oct 25, 2026, 19:34Christophe Nougier: Returning to Burundi for the WFH-Supported Twinning Project
-
Oct 25, 2026, 19:23Özlem Turan: Advancing Care for Women and Girls With Bleeding Disorders at the European Parliament
-
Oct 25, 2026, 18:36James P. Crowley: Gene Inactivation and Targeted Gene Repair as Two Approaches to CRISPR Gene Editing
-
Oct 25, 2026, 17:43Jan Sloves: Femoral Vein Aneurysm and Chronic Venous Obstruction
-
Oct 25, 2026, 17:31Kasimu Hussaini: Blood Component Therapy From Whole Blood to Targeted Treatment
-
Oct 25, 2026, 17:23Zahra Safarzadeh: When Low Factor VII Activity and Reduced VWF Antigen Coexist
-
Oct 25, 2026, 17:17Anubhav Joshi: Evans Syndrome in CLL A Differential Diagnosis to Remember